Skip to content

Ultrasound-guided continuous brachial plexus block via costoclavicular approach for postoperative analgesia in patients undergoing shoulder arthroscopic surgery:effectiveness and safety trial

Ultrasound-guided continuous brachial plexus block via costoclavicular approach for postoperative analgesia in patients undergoing shoulder arthroscopic surgery:effectiveness and safety trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068772
Enrollment
Unknown
Registered
2023-02-28
Start date
2023-03-01
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder joint disease

Interventions

CCB group:Methods of postoperative analgesia
ISB group:Postoperative analgesia via intermuscular sulcus approach of brachial plexus block

Sponsors

The Second Affiliated Hospital of Medical College of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years; 2. ASA class I-II; 3. Patients undergoing elective shoulder arthroscopic surgery agreed to use a continuous nerve block postoperative analgesia pump.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Complicated with severe primary diseases such as lung, liver, kidney, cardiovascular system and hematopoietic system; 3. Bleeding Tendency or Coagulopathy; 4. Previous history of collarbone, neck region surgery, nerve injury or neurological disorder; 5. History of allergic reaction to local anesthetics, skin infection at puncture site, or contraindications to concurrent regional block anesthesia; 6. The patients with previous history of nervous and mental system diseases: craniocerebral injury, convulsion, epilepsy, intracranial hypertension, cerebrovascular accident; Or schizophrenia, mania, long-term use of psychotropic drugs, cognitive impairment history, can not read, understand and communicate; 7. Patients with obstructive or restrictive lung disease; 8. Obesity (BMI > 30 kg/m 2).

Design outcomes

Primary

MeasureTime frame
Mean NRS pain score at rest 24 hours after infusion of nerve block analgesia pump.;

Secondary

MeasureTime frame
Ultrasound imaging time;The time of insertion;Effective time and success rate;Incidence of hemidiaphragm paralysis (HDP);Postoperative adverse reactions;Education level;Anesthetic time;0peration time;Total remifentanil dose;Number of anchors;The highest resting pain before operation;Number of passes;Horner syndrome;Vascular puncture;Nerve puncture;Total NBPCA dose (ml) ;Number of NBPCA presses;Tramadol consumption 48h after surgery(mg);Sleep quality 48h after surgery;patient satisfaction with analgesia 48h after surgery;surgeon satisfaction with analgesia 48h after surgery;

Countries

China

Contacts

Public ContactYao Yuanyuan

The Second Affiliated Hospital of Medical College of Zhejiang University

yuanyuan58@126.com+86 135 8887 2603

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026